Retraction. Fenofibrate improves the impaired endothelial progenitor cell function through inhibiting eNOS uncoupling in diabetic mice.

Unlabelled: The above article, published online on 24 December 2014 as an Accepted Article in Wiley Online Library (http://onlinelibrary.wiley.com/doi/10.1111/bph.13054/abstract), has been retracted by agreement between the authors, the journal Editor in Chief, Professor J. McGrath and John Wiley & Sons Limited. The retraction has been agreed owing to duplication of some images. In this paper, there is a figure duplication in Figure 8A (‘Control’ is from an identical tissue slice as ‘STZ+FF’). There are also partially overlapping figures in supplemental figures S3 and S5. The authors explain this as follows: ‘Our technician took fluorescence images and saved them in one folder using the Arabic numerals. Then we use[d] Photoshop to arrange the images. We chose the STZ+FF group image from the Control group by mistake.’.

Reference: Zhao Ting, Deng Ya‐Ping, Ni Min, Chen Ji‐Kuai, Li Zhang‐Peng, Li Dong‐Jie and Shen Fu‐Ming (2014), Fenofibrate improves the impaired endothelial progenitor cell function through inhibiting eNOS uncoupling in diabetic mice. Br J Pharmacol, doi: 10.1111/bph.13054